Disease activity impacts disability progression in primary progressive multiple sclerosis

被引:16
|
作者
Marrodan, M. [1 ]
Bensi, C. [1 ]
Pappolla, A. [2 ]
Rojas, J. I. [2 ,3 ]
Gaitan, M. I. [1 ]
Ysrraelit, M. C. [1 ]
Negrotto, L. [1 ]
Fiol, M. P. [1 ]
Patrucco, L. [2 ,3 ]
Cristiano, E. [3 ]
Farez, M. F. [1 ,4 ]
Correale, J. [1 ]
机构
[1] Fleni, Dept Neurol, Montaneses 2325, RA-1428 Buenos Aires, DF, Argentina
[2] Hosp Italiano Buenos Aires, Dept Neurol, Buenos Aires, DF, Argentina
[3] Ctr Esclerosis Multiple Buenos Aires, Buenos Aires, DF, Argentina
[4] Fleni, Ctr Biostat Epidemiol & Publ Hlth CEBES, Buenos Aires, DF, Argentina
关键词
Primary progressive multiple sclerosis; PPMS; Multiple Sclerosis; Disability worsening; Disability progression; NATURAL-HISTORY; PROGNOSTIC-FACTORS; MRI; MS; PREDICTORS;
D O I
10.1016/j.msard.2019.101892
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Although solid information on the natural history of primary progressive multiple sclerosis (PPMS) is available, evidence regarding impact of disease activity on PPMS progression remains controversial. Objective: To describe the clinical characteristics, presence or absence of MRI activity, and natural history of a PPMS cohort from two referral centers in Argentina and assess whether clinical and/or radiological disease activity correlated with disability worsening. Methods: Retrospective study conducted at two MS clinics in Buenos Aires, Argentina, through comparative analysis of patients with and without evidence of disease activity. Results: Clinical and/or radiologic activity was presented in 56 (31%) of 178 patients. When stratified by age at onset, we found that for every 10 years of increase in age at onset, risk of reaching EDSS scores of 4 and 6 increased by 26% and 31%, respectively (EDSS 4: HR 1.26, CI 95%: 1.06-1.50; EDSS 6: HR 1.31, CI 95%: 1.06-1.62). Patients who presented clinical exacerbations reached EDSS scores of 6, 7 and 8 faster than those without associated exacerbations (p = 0.009, p = 0.016 and p = 0.001, respectively). Likewise, patients who presented gadolinium-enhancing lesions during the course of disease reached EDSS scores of 7 earlier (p = 0.002). Conclusion: Older age at onset and presence of clinical and/or radiological disease activity correlated with accelerated disability progression in this cohort of PPMS patients.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Changes in Brain Volume in Specific Regions could be related to Disability Progression in Primary Progressive Multiple Sclerosis Patients
    Perez Miralles, Francisco
    Prefasi, Daniel
    Garcia-Merino, Antonio
    Ramon Ara, Jose
    Izquierdo Ayuso, Guillermo
    Meca Lallana, Virginia
    Gascon, Francisco
    Martinez Gines, Maria Luisa
    Ramio Torrenta, Lluis
    Costa Frossard, Lucienne
    Fernandez, Oscar
    Moreno Garcia, Sara
    Maurino, Jorge
    Casanova, Bonaventura
    NEUROLOGY, 2019, 92 (15)
  • [42] Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis
    Elliott, Colm
    Belachew, Shibeshih
    Wolinsky, Jerry S.
    Hauser, Stephen L.
    Kappos, Ludwig
    Barkhof, Frederik
    Bernasconi, Corrado
    Fecker, Julian
    Model, Fabian
    Wei, Wei
    Arnold, Douglas L.
    BRAIN, 2019, 142 : 2787 - 2799
  • [43] Smoking does not influence disability accumulation in primary progressive multiple sclerosis
    Javizian, O.
    Metz, L. M.
    Deighton, S.
    Koch, M. W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 (04) : 624 - 630
  • [44] Physical activity monitoring to assess disability progression in multiple sclerosis
    Stuart, Charlotte M.
    Varatharaj, Aravinthan
    Domjan, Janine
    Philip, Sheaba
    Galea, Ian
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2020, 6 (04)
  • [45] Multiple sclerosis that is progressive from the time of onset -: Clinical characteristics and progression of disability
    Andersson, PB
    Waubant, E
    Gee, L
    Goodkin, DE
    ARCHIVES OF NEUROLOGY, 1999, 56 (09) : 1138 - 1142
  • [46] Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis
    Abdelhak, Ahmed
    Antweiler, Kai
    Kowarik, Markus C.
    Senel, Makbule
    Havla, Joachim
    Zettl, Uwe K.
    Kleiter, Ingo
    Skripuletz, Thomas
    Haarmann, Axel
    Stahmann, Alexander
    Huss, Andre
    Gingele, Stefan
    Krumbholz, Markus
    Benkert, Pascal
    Kuhle, Jens
    Friede, Tim
    Ludolph, Albert C.
    Ziemann, Ulf
    Kuempfel, Tania
    Tumani, Hayrettin
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (02): : 477 - 485
  • [47] Fingolimod effect on disability progression in primary progressive multiple sclerosis patients with inflammatory activity: A post-hoc subgroup analysis of the INFORMS study
    Wolinsky, J. S.
    Cree, B. A. C.
    Freedman, M. S.
    Hartung, H. -P.
    Lublin, F.
    Miller, D. H.
    Montalban, X.
    Uitdehaag, B.
    Weiner, H.
    Lubetzki, C.
    Putzki, N.
    Li, B.
    Haring, D. A.
    Merschhemke, M.
    Kappos, L.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 679 - 680
  • [48] Multimodal Evoked Potentials in Primary Progressive Multiple Sclerosis: Identification of Patients at Risk for Disease Progression
    Hardmeier, M.
    Schlaeger, R.
    Lascano, A.
    Toffolet, L.
    Schindler, C.
    Gobbi, C.
    D'epinay, P. Lalive
    Kuhle, J.
    Kappos, L.
    Fuhr, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 330 - 330
  • [49] Modifying disability in progressive multiple sclerosis
    Palace, Jacqueline
    Robertson, Neil
    LANCET, 2014, 383 (9936): : 2189 - 2191
  • [50] Managing Disability in Progressive Multiple Sclerosis
    Dubey, Divyanshu
    Sguigna, Peter
    Stuve, Olaf
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2016, 18 (06)